|
HNRNPAB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.88657986402541E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19599893824807E-11 |
| Normal-vs-Stage2 |
1.742780E-03 |
| Normal-vs-Stage3 |
2.44549999999233E-05 |
| Normal-vs-Stage4 |
1.241820E-02 |
| Stage1-vs-Stage2 |
2.587400E-01 |
| Stage1-vs-Stage3 |
3.912200E-02 |
| Stage1-vs-Stage4 |
2.046600E-01 |
| Stage2-vs-Stage3 |
1.114400E-02 |
| Stage2-vs-Stage4 |
1.040570E-01 |
| Stage3-vs-Stage4 |
9.803600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67621472257906E-12 |
| Normal-vs-AfricanAmerican |
3.95569998978829E-09 |
| Normal-vs-Asian |
8.779700E-02 |
| Caucasian-vs-AfricanAmerican |
3.554000E-01 |
| Caucasian-vs-Asian |
3.174000E-01 |
| AfricanAmerican-vs-Asian |
4.354400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65445435129641E-12 |
| Normal-vs-Female |
1.64950000325348E-08 |
| Male-vs-Female |
8.638000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.37529999999042E-05 |
| Normal-vs-Extreme_Weight |
1.38433708940511E-12 |
| Normal-vs-Obese |
1.13260001377569E-09 |
| Normal-vs-Extreme_Obese |
6.838200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.195400E-01 |
| Normal_Weight-vs-Obese |
5.711400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.917400E-01 |
| Extreme_Weight-vs-Obese |
4.397200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.365960E-01 |
| Obese-vs-Extreme_Obese |
2.436600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.842950E-03 |
| Normal-vs-Age(41-60Yrs) |
5.08482145278322E-14 |
| Normal-vs-Age(61-80Yrs) |
7.32219840315906E-11 |
| Normal-vs-Age(81-100Yrs) |
4.618700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.203800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.213400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.323200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.722600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.803400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.878800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62714286489063E-12 |
| Normal-VS-Type2 PRCC |
1.5503999994948E-07 |
| Normal-VS-KIRP CIMP |
2.940300E-03 |
| Normal-VS-Unclassified PRCC |
5.569100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.640800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.468100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.247000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.600300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.600000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.688800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.11829999996871E-07 |
| Normal-vs-N1 |
1.380610E-04 |
| Normal-vs-N2 |
3.313000E-01 |
| N0-vs-N1 |
7.783900E-02 |
| N0-vs-N2 |
6.703000E-01 |
| N1-vs-N2 |
9.534000E-01 |
|
|
